Form 8-K - Current report:
SEC Accession No. 0001104659-08-073190
Filing Date
2008-11-26
Accepted
2008-11-26 06:01:38
Documents
7
Period of Report
2008-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-29085_18k.htm 8-K 48322
2 EX-10.1 a08-29085_1ex10d1.htm EX-10.1 35762
3 EX-10.2 a08-29085_1ex10d2.htm EX-10.2 503767
4 EX-99.1 a08-29085_1ex99d1.htm EX-99.1 16734
5 EX-99.2 a08-29085_1ex99d2.htm EX-99.2 17227
6 GRAPHIC g290851moi001.jpg GRAPHIC 2778
7 GRAPHIC g290851mmi001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-08-073190.txt   631569
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 081215479
SIC: 2834 Pharmaceutical Preparations